SIGY — Sigyn Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Sigyn Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.001	0.084	0.341	0.008	0.012
Net Total Accounts Receivable
Net Total Receivables	—	—	0	—	—
Total Inventory
Total Other Current Assets
Total Current Assets	0.589	0.67	0.393	0.07	0.118
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.003	0.002	0.291	0.24	0.183
Net Intangible Assets
Other Long Term Assets
Total Assets	0.642	0.694	0.71	0.333	0.322
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.1	0.595	0.734	2.05	3.61
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.1	0.595	0.975	2.24	3.73
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.46	0.099	-0.265	-1.9	-3.41
Total Liabilities & Shareholders' Equity	0.642	0.694	0.71	0.333	0.322
Total Common Shares Outstanding